Bli medlem
Bli medlem

Du är här


C-RAD receives the first two orders from General Electric

rders from General Electric

Press release 2016-11-09

C-RAD has received the first order for two Sentinel 4DCT systems from General
Electric. The systems are ordered for customers in Europe. The total order
value is approximately 1 MSEK.

C-RAD and GE Healthcare have entered a sales and distribution agreement for
Sentinel 4DCT™ systems and Cyrpa High Impact Technology (HIT) laser systems end
of last year. These systems are used for 4D imaging and virtual simulation in
radiation therapy. GE offers these solutions through its price book, making
them available to the GE salesforce and their customers worldwide.

“I am pleased to announce the first orders through General Electric. We are
working intensively on training the local GE organizations on the C-RAD
products. To provide the sales organization with the expertise required to
promote the C-RAD systems as part of their projects.” says Tim Thurn, CEO C-RAD

About C-RAD

C-RAD develops innovative solutions for use in advanced radiation therapy. The
C-RAD group offers products and solutions for patient positioning, tumor
localization and radiation treatment systems. All product development is
conducted in three fully owned subsidiaries: C-RAD Positioning AB, C-RAD
Imaging AB and C-RAD Innovation AB, all of which are located in Uppsala,
Sweden. C-RAD has established three companies for direct sales: C-RAD Inc. in
the US, C-RAD GmbH in Germany and C-RAD WOFE in China. Cyrpa International
SPRL, a Franco-Belgian laser company, is a wholly owned subsidiary whose
operations are integrated. C-RAD AB is listed on NASDAQ Stockholm.

For more information on C-RAD, please visit

For further information:

Tim Thurn, CEO C-RAD AB, Phone +46-18-666930, Email

This information is information that C-RAD AB (publ) is obliged to make public
pursuant to the EU Market Abuse Regulation. The information was submitted for
publication at 08:30 CET on November 9, 2016

Författare SSE

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.